Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Adeshakin, AO"'
Publikováno v:
Biokemistri; Vol 24, No 1 (2012); 23-30
β-Amylase (á-1, 4 glucan maltohydrolase; E.C:3.2.1.2) is used in the food processing, brewing and distilling industries due to its capacity to produce maltose syrup from starch. Here, we report the purification and characterization of â-amylase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=78975075580c::686cf20c39e8b15e636f7026bfb9b81e
https://www.ajol.info/index.php/biokem/article/view/88717
https://www.ajol.info/index.php/biokem/article/view/88717
Autor:
Adeshakin AO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing , China.; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, United States., Adeshakin FO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing , China., Yan D; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing , China., Wan X; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing , China.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Jan 24; Vol. 13, pp. 781660. Date of Electronic Publication: 2022 Jan 24 (Print Publication: 2022).
Autor:
Adeshakin FO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.; University of Chinese Academy of Sciences, Beijing 100864, China., Adeshakin AO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.; University of Chinese Academy of Sciences, Beijing 100864, China., Liu Z; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China., Cheng J; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China., Zhang P; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.; University of Chinese Academy of Sciences, Beijing 100864, China., Yan D; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.; University of Chinese Academy of Sciences, Beijing 100864, China., Zhang G; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China., Wan X; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.; University of Chinese Academy of Sciences, Beijing 100864, China.
Publikováno v:
Life (Basel, Switzerland) [Life (Basel)] 2021 Dec 28; Vol. 12 (1). Date of Electronic Publication: 2021 Dec 28.
Autor:
Afolabi LO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Bi J; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China.; CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Li X; Department of Stomatology, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen, China., Adeshakin AO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Adeshakin FO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Wu H; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Yan D; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Chen L; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Wan X; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Aug 31; Vol. 12, pp. 701671. Date of Electronic Publication: 2021 Aug 31 (Print Publication: 2021).
Autor:
Adeshakin FO; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China., Adeshakin AO; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China., Liu Z; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China., Lu X; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China., Cheng J; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; School of Basic Medical Science, Jinzhou Medical University, Jinzhou, 121000, China., Zhang P; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China., Yan D; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China., Zhang G; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China., Wan X; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China.
Publikováno v:
Journal of Cancer [J Cancer] 2021 Jun 11; Vol. 12 (16), pp. 4819-4829. Date of Electronic Publication: 2021 Jun 11 (Print Publication: 2021).
Autor:
Adeshakin AO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, Beijing 100864, China., Liu W; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China., Adeshakin FO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, Beijing 100864, China., Afolabi LO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, Beijing 100864, China., Zhang M; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; School of Basic Medical Science, Jinzhou Medical University, Jinzhou 121000, China., Zhang G; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China., Wang L; Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518036, China., Li Z; Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan 523000, China., Lin L; Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan 523000, China., Cao Q; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China., Yan D; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, Beijing 100864, China. Electronic address: dh.yan@siat.ac.cn., Wan X; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, Beijing 100864, China; Shenzhen BinDeBioTech Co., Ltd, Shenzhen 518055, China. Electronic address: xc.wan@siat.ac.cn.
Publikováno v:
Cellular immunology [Cell Immunol] 2021 Apr; Vol. 362, pp. 104286. Date of Electronic Publication: 2021 Jan 19.
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming.
Autor:
Adeshakin FO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Adeshakin AO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Afolabi LO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Yan D; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Zhang G; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Wan X; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Mar 29; Vol. 11, pp. 626577. Date of Electronic Publication: 2021 Mar 29 (Print Publication: 2021).
Autor:
Adeshakin AO; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China., Adeshakin FO; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China., Liu W; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China., Li H; SUSTech Core Research Facilities, Southern University of Science and Technology, Shenzhen, 518055 China., Yan D; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China., Wan X; Guangdong Immune Cell therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; University of Chinese Academy of Sciences, Beijing, 100864, China.
Publikováno v:
Data in brief [Data Brief] 2021 Feb 13; Vol. 35, pp. 106882. Date of Electronic Publication: 2021 Feb 13 (Print Publication: 2021).
Autor:
Adeshakin AO; Shenzhen Laboratory for Human Antibody Engineering, Center for Protein and Cell-based Drugs, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China; University of Chinese Academy of Sciences, Beijing, 100864, China., Yan D; Shenzhen Laboratory for Human Antibody Engineering, Center for Protein and Cell-based Drugs, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China., Zhang M; Shenzhen Laboratory for Human Antibody Engineering, Center for Protein and Cell-based Drugs, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China; School of Basic Medical Science, Jinzhou Medical University, Jinzhou, 121000, China., Wang L; Department of Pediatrics, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China., Adeshakin FO; Shenzhen Laboratory for Human Antibody Engineering, Center for Protein and Cell-based Drugs, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China; University of Chinese Academy of Sciences, Beijing, 100864, China., Liu W; Shenzhen Laboratory for Human Antibody Engineering, Center for Protein and Cell-based Drugs, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China., Wan X; Shenzhen Laboratory for Human Antibody Engineering, Center for Protein and Cell-based Drugs, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China; University of Chinese Academy of Sciences, Beijing, 100864, China. Electronic address: xc.wan@siat.ac.cn.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2020 Feb 12; Vol. 522 (3), pp. 604-611. Date of Electronic Publication: 2019 Nov 28.
Autor:
Afolabi LO; Shenzhen Laboratory of Antibody Engineering, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China.; Department of Biochemistry, Faculty of Science, Federal University Dutse, Dutse, Jigawa State, Nigeria., Adeshakin AO; Shenzhen Laboratory of Antibody Engineering, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China., Sani MM; Department of Biochemistry, Faculty of Science, Federal University Dutse, Dutse, Jigawa State, Nigeria., Bi J; Shenzhen Laboratory of Antibody Engineering, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Wan X; Shenzhen Laboratory of Antibody Engineering, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; University of Chinese Academy of Sciences, Beijing, China.
Publikováno v:
Immunology [Immunology] 2019 Oct; Vol. 158 (2), pp. 63-69. Date of Electronic Publication: 2019 Aug 14.